Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
https://doi.org/10.1016/s1470-2045(21)00493-9
P
Pierandrea De Iaco
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
375
Papers
7.2K
Citations
47
h-index
147
i10-index
Pierandrea De Iaco is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Uterine Myomas and Treatments. The author has an h-index of 47, co-authored 319 publications.
ORCID: 0000-0002-8841-6531Papers by this author
worksElective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
2020 · Journal of Clinical Oncology · 222 citations
https://doi.org/10.1200/jco.20.01933
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer
2021 · Annals of Oncology · 152 citations
https://doi.org/10.1016/j.annonc.2021.11.013
Delaying surgery for patients with a previous SARS-CoV-2 infection
2020 · British journal of surgery · 143 citations
https://doi.org/10.1002/bjs.12050
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
2016 · Annals of Surgical Oncology · 97 citations
https://doi.org/10.1245/s10434-016-5686-1
Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study
2015 · Journal of Gynecologic Oncology · 83 citations
https://doi.org/10.3802/jgo.2015.26.1.54
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat